Latest Breaking News On - Judith mcgarry - Page 1 : comparemela.com

Aurion Biotech to Present Clinical Data at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Aurion Biotech Announces First Canadian Subject Dosed in Phase 1 / 2 Clinical Trial

SEATTLE & CAMBRIDGE, Mass. & TOKYO, March 28, 2024 Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced that it has dosed the first Canadian subject in its Phase 1 / 2 clinical trial (ABA-1, CLARA) of AURN001, a cell therapy for the treatment of corneal edema secondary to corneal endothelial dysfunction.

How biotech companies are standing out during JPM Week

Early-stage biotechs are looking to capture investors’ ‘head and heart’ by working the sidelines of the big event.

Greg Kunst, CEO of Aurion Biotech, Receives Healthcare Leadership Award from Puget Sound Business Journal

Aurion Biotech Named "Regenerative Therapeutics Company Of The Year" By BioTech Breakthrough